Target v. Cordis/SciMed: ruling on implementation of preliminary injunction expected May 21.
This article was originally published in The Gray Sheet
Executive Summary
SCIMED/CORDIS MOTION TO CONTINUE STAY ON GUIDEWIRE/MICROCATHETER preliminary injunction will be reviewed by Judge Robert Aguilar, U.S. District Court in San Francisco, at a May 21 hearing. On May 2, Aguilar granted Target Therapeutics' motion to impose a preliminary injunction prohibiting Cordis and SciMed from selling certain microcatheter and guidewire products. However, he also placed a temporary stay on the injunction pending the upcoming hearing.